Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 482天前

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 637天前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 753天前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1127天前

European Shares Set To Follow Wall Street Lower

European stocks may drift lower at open on Wednesday after U.S. stock markets retreated from record highs overnight on apprehensions about the outlook for interest-rate cuts.

RTTNews | 1小時28分鐘前

Japan Private Sector Growth Weakest In 4 Months

Japan's private sector grew at the slowest pace in four months in September as the strong rise in services activity was partially offset by a steeper fall in manufacturing production, flash survey data published by S&P Global showed on Wednesday. The flash composite output index fell to 51.1 in September from a six-month high of 52.0 in August.

RTTNews | 1小時58分鐘前

Sensex, Nifty Extend Losses For Fourth Day

Indian shares opened on a sluggish note on Wednesday after U.S. President Donald Trump accused India and China of being the primary funders of Russia's war in Ukraine through their continued purchase of Russian oil.

RTTNews | 2小時14分鐘前

Australian Market Doubles Early Losses In Mid-market

The Australian stock market is doubling its early losses in mid-market moves on Wednesday, snapping a three-session winning streak, with the benchmark S&P/ASX 200 falling below the 8,800 level, following the broadly negative cues from Wall Street overnight, with weakness in gold miners, financial and technology stocks partially offset by gains in iron ore miners and energy stocks.

RTTNews | 3小時42分鐘前

EURUSD	1.17903	GBPUSD	1.34956	AUDUSD	0.66191
USDJPY	148.041	USDCAD	1.38533	USDCHF	0.79293